BlackRock’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.04B | Buy |
125,919,853
+4,925,379
| +4% | +$379M | 0.16% | 111 |
|
|
2025
Q4 | $9.6B | Buy |
120,994,474
+1,158,330
| +1% | +$91.3M | 0.16% | 98 |
|
|
2025
Q3 | $9.03B | Sell |
119,836,144
-2,850,536
| -2% | -$195M | 0.16% | 104 |
|
|
2025
Q2 | $8.46B | Buy |
122,686,680
+10,093,204
| +9% | +$662M | 0.16% | 108 |
|
|
2025
Q1 | $7.63B | Buy |
112,593,476
+6,627,634
| +6% | +$397M | 0.16% | 112 |
|
|
2024
Q4 | $4.76B | Buy |
105,965,842
+1,416,331
| +1% | +$79.5M | 0.1% | 171 |
|
|
2024
Q3 | $6.57B | Buy |
104,549,511
+4,398,293
| +4% | +$257M | 0.14% | 120 |
|
|
2024
Q2 | $5.91B | Buy |
100,151,218
+13,049,782
| +15% | +$816M | 0.13% | 121 |
|
|
2024
Q1 | $6.95B | Buy |
87,101,436
+78,437
| +0.1% | +$5.99M | 0.16% | 106 |
|
|
2023
Q4 | $6.87B | Buy |
87,022,999
+289,036
| +0.3% | +$20.6M | 0.18% | 103 |
|
|
2023
Q3 | $6.06B | Sell |
86,733,963
-7,000,887
| -7% | -$496M | 0.17% | 100 |
|
|
2023
Q2 | $6.48B | Buy |
93,734,850
+261,789
| +0.3% | +$18.6M | 0.18% | 99 |
|
|
2023
Q1 | $6.95B | Sell |
93,473,061
-1,501,021
| -2% | -$126M | 0.2% | 89 |
|
|
2022
Q4 | $8.85B | Buy |
94,974,082
+1,123,455
| +1% | +$108M | 0.28% | 66 |
|
|
2022
Q3 | $8.95B | Sell |
93,850,627
-627,464
| -0.7% | -$62.1M | 0.3% | 53 |
|
|
2022
Q2 | $8.75B | Buy |
94,478,091
+1,511,481
| +2% | +$148M | 0.28% | 64 |
|
|
2022
Q1 | $9.41B | Sell |
92,966,610
-589,891
| -0.6% | -$62M | 0.25% | 64 |
|
|
2021
Q4 | $9.65B | Sell |
93,556,501
-1,038,447
| -1% | -$96M | 0.25% | 68 |
|
|
2021
Q3 | $8.03B | Sell |
94,594,948
-1,895,062
| -2% | -$159M | 0.22% | 79 |
|
|
2021
Q2 | $8.05B | Buy |
96,490,010
+1,927,510
| +2% | +$158M | 0.22% | 78 |
|
|
2021
Q1 | $7.11B | Buy |
94,562,500
+2,084,131
| +2% | +$152M | 0.21% | 84 |
|
|
2020
Q4 | $6.32B | Sell |
92,478,369
-7,805,909
| -8% | -$508M | 0.2% | 85 |
|
|
2020
Q3 | $5.86B | Buy |
100,284,278
+3,127,908
| +3% | +$195M | 0.22% | 82 |
|
|
2020
Q2 | $6.31B | Buy |
97,156,370
+1,707,819
| +2% | +$108M | 0.25% | 69 |
|
|
2020
Q1 | $5.66B | Buy |
95,448,551
+1,290,541
| +1% | +$86.2M | 0.28% | 65 |
|
|
2019
Q4 | $7B | Buy |
94,158,010
+834,227
| +0.9% | +$58.6M | 0.27% | 67 |
|
|
2019
Q3 | $5.89B | Buy |
93,323,783
+3,160,182
| +4% | +$187M | 0.25% | 70 |
|
|
2019
Q2 | $4.91B | Sell |
90,163,601
-2,362,926
| -3% | -$127M | 0.21% | 82 |
|
|
2019
Q1 | $4.99B | Sell |
92,526,527
-428,431
| -0.5% | -$26.4M | 0.22% | 76 |
|
|
2018
Q4 | $6.09B | Buy |
92,954,958
+16,757,941
| +22% | +$1.25B | 0.31% | 58 |
|
|
2018
Q3 | $6B | Buy |
76,197,017
+2,061,915
| +3% | +$147M | 0.26% | 71 |
|
|
2018
Q2 | $4.77B | Buy |
74,135,102
+4,121,620
| +6% | +$272M | 0.22% | 79 |
|
|
2018
Q1 | $4.36B | Buy |
70,013,482
+3,016,972
| +5% | +$216M | 0.21% | 86 |
|
|
2017
Q4 | $4.86B | Buy |
66,996,510
+2,430,476
| +4% | +$177M | 0.23% | 78 |
|
|
2017
Q3 | $5.25B | Buy |
64,566,034
+2,964,930
| +5% | +$235M | 0.26% | 68 |
|
|
2017
Q2 | $4.96B | Sell |
61,601,104
-2,013,985
| -3% | -$159M | 0.26% | 67 |
|
|
2017
Q1 | $4.99B | Buy |
63,615,089
+60,713,487
| +2,092% | +$4.85B | 0.27% | 63 |
|
|
2016
Q4 | $229M | Buy |
2,901,602
+467,840
| +19% | +$37.9M | 0.32% | 59 |
|
|
2016
Q3 | $217M | Sell |
2,433,762
-289,362
| -11% | -$27.3M | 0.31% | 62 |
|
|
2016
Q2 | $261M | Sell |
2,723,124
-8,954
| -0.3% | -$892K | 0.39% | 50 |
|
|
2016
Q1 | $283M | Sell |
2,732,078
-917,181
| -25% | -$89.2M | 0.46% | 40 |
|
|
2015
Q4 | $357M | Buy |
3,649,259
+319,029
| +10% | +$31.2M | 0.52% | 40 |
|
|
2015
Q3 | $321M | Buy |
3,330,230
+301,360
| +10% | +$31.7M | 0.5% | 40 |
|
|
2015
Q2 | $318M | Sell |
3,028,870
-565,034
| -16% | -$57.7M | 0.47% | 46 |
|
|
2015
Q1 | $371M | Buy |
3,593,904
+309,282
| +9% | +$31.3M | 0.51% | 41 |
|
|
2014
Q4 | $316M | Sell |
3,284,622
-26,787
| -0.8% | -$2.36M | 0.45% | 50 |
|
|
2014
Q3 | $264M | Sell |
3,311,409
-58,237
| -2% | -$4.59M | 0.39% | 54 |
|
|
2014
Q2 | $254M | Buy |
3,369,646
+67,818
| +2% | +$5.13M | 0.38% | 55 |
|
|
2014
Q1 | $247M | Sell |
3,301,828
-691,341
| -17% | -$48.8M | 0.4% | 54 |
|
|
2013
Q4 | $286M | Buy |
3,993,169
+515,455
| +15% | +$33.1M | 0.47% | 45 |
|
|
2013
Q3 | $197M | Sell |
3,477,714
-259,140
| -7% | -$15.4M | 0.37% | 58 |
|
|
2013
Q2 | $214M | Buy |
+3,736,854
| New | +$216M | 0.42% | 50 |
|
Other funds holding CVS
VCM
VPM
BlackRock's CVS Position: Q1 2026 in Review
BlackRock increased its CVS Health (CVS) stake by 4.1% in Q1 2026, buying an estimated $379M and bringing the position to 125,919,853 shares worth $9.04B. The position accounts for 0.16% of the portfolio, ranked #111.
BlackRock first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.65B in Q4 2021. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- BlackRock held 125,919,853 shares of CVS Health worth $9.04B as of Q1 2026.
- BlackRock bought 4,925,379 CVS Health shares in Q1 2026, an estimated $379M.
- CVS Health made up 0.16% of BlackRock's portfolio in Q1 2026, its #111 holding.
- BlackRock first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- BlackRock's CVS Health position peaked at $9.65B in Q4 2021.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.